Dextromethorphan and other N-methyl-D-aspartate receptor antagonists are teratogenic in the avian embryo model

Pediatric Research

Volumn 43, Issue 1, 1998, Pages 1-7

  Andaloro, Vincent J ^a   Monaghan, Daniel T ^a   Rosenquist, Thomas H ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROMETHORPHAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRD; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; EMBRYOTOXICITY; ENVIRONMENTAL EXPOSURE; NERVE CELL DIFFERENTIATION; NEURAL CREST; NEURAL TUBE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; TERATOGENICITY;

EID: 0031941364     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199801000-00001     Document Type: Article

References (71)

1. Serbedzija GN, Bronner Fraser M, Fraser SE 1994 Developmental potential of trunk neural crest cells in the mouse. Development 120:1709-1718
2. Nickel RE, Pillers DA, Merkens M, Magenis RE, Driscoll DA, Emanuel BS, Zonana J 1994 Velo-cardio-facial syndrome and DiGeorge sequence with meningomyelocele and deletions of the 22q11 region. Am J Med Genet 52:445-449
3. Guttormsen AB, Schneede J, Ueland PM, Refsum H 1996 Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency. Am J Clin Nutr 63:194-202
4. Stabler SP, Lindenbaum J, Allen RH 1996 The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency. J Nutr 126:1266s-1272s
5. Rosenquist TH, Ratashak SA, Selhub J 1996 Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 93:15227-15232
6. Kim WK, Rayudu PV, Choi YB, Kumar S, Stamler JS, Lipton SA 1995 Homocysteine: an NMDA agonist and glycine site partial agonist that induces cortical neurotoxicity. Soc Neurosci Abstr 1995
7. Kim WK, Pae YS 1996 Involvement of N-methyl-D-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture. Neurosci Lett 216:117-120
8. Lovinger DM, White G, Weight FF 1989 Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243:1721-1724
9. Grant KA, Lovinger DM 1995 Cellular and behavioral neurobiology of alcohol: receptor-mediated neuronal processes. Clin Neurosci 3:155-164
10. Hoffman PL, Tabakoff B 1996 Alcohol dependence: a commentary on mechanisms. Alcohol 31:333-340
11. Bhave SV, Snell LD, Tabakoff B, Hoffman PL 1996 Mechanism of ethanol inhibition of NMDA receptor function in primary cultures of cerebral cortical cells. Alcohol Clin Exp Res 20:934-941
12. Tsai G, Gastfriend DR, Coyle JT 1995 The glutamatergic basis of human alcoholism [see comments]. Am J Psychiatry 152:332-340
13. Bove FJ 1996 Public drinking water contamination and birthweight, prematurity, fetal deaths, and birth defects. Toxicol Ind Health 12:255-266
14. Bove FJ, Fulcomer MC, Klotz JB, Esmart J, Dufficy EM, Savrin JE 1995 Public drinking water contamination and birth outcomes [see comments]. Am J Epidemiol 141:850-862
15. Elovaara E, Hemminki K, Vainio H 1979 Effects of methylene chloride, trichloroethane, trichloroethylene, tetrachloroethylene and toluene on the development of chick embryos. Toxicology 12:111-119
16. 3H]MK-801 binding and reversal by glycine. Neurosci Lett 132:73-76
17. Aronstam RS, Martin DC, Dennison RL 1994 Volatile anesthetics inhibit NMDA-stimulated 45Ca uptake by rat brain microvesicles. Neurochem Res 19:1515-1520
18. 3H]MK-801) binding to N-methyl-D-aspartate (NMDA) receptors in rat brain. Biochem Pharmacol 50:1373-1377
19. Martin DC, Plagenhoef M, Abraham J, Dennison RL, Aronstam RS 1995 Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem Pharmacol 49:809-817
20. Daniell LC 1994 Effect of anesthetic and convulsant barbiturates on N-methyl-D-aspartate receptor-mediated calcium flux in brain membrane vesicles. Pharmacology 49:296-307
21. Choi DW, Peters S, Viseskul V 1987 Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons. J Pharmacol Exp Ther 242:713-720
22. Ferkany JW, Borosky SA, Clissold DB, Pontecorvo MJ 1988 Dextromethorphan inhibits NMDA-induced convulsions. Eur J Pharmacol 151:151-154
23. Monaghan DT, Bridges RJ, Cotman CW 1989 The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365-402
24. Collingridge GL, Lester RA 1989 Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev 41:143-210
25. McBain CJ, Mayer ML 1994 N-Methyl-D-aspartic acid receptor structure and function. Physiol Rev 74:723-760
26. Monaghan DT, Buller AL, Andaloro VJ 1996 On the molecular basis of NMDA receptor diversity. In: Ionotropic Glutamate Receptors. Humana Press, Tottowa, NJ
27. Sucher NJ, Awobuluyi M, Choi YB, Lipton SA 1996 NMDA receptors: from genes to channels. Trends Pharmacol Sci 17:348-355
28. Scheetz AJ, Constantine Paton M 1994 Modulation of NMDA receptor function: implications for vertebrate neural development. FASEB J 8:745-752
29. Cambray Deakin MA, Foster AC, Burgoyne RD 1990 The expression of excitatory amino acid binding sites during neuritogenesis in the developing rat cerebellum. Brain Res Dev Brain Res 54:265-271
30. Burgoyne RD, Graham ME, Cambray Deakin M 1993 Neurotrophic effects of NMDA receptor activation on developing cerebellar granule cells. J Neurocytol 22:689-695
31. Farrant M, Feldmeyer D, Takahashi T, Cull Candy SG 1994 NMDA-receptor channel diversity in the developing cerebellum. Nature 368:335-339
32. Komuro H, Rakic P 1993 Modulation of neuronal migration by NMDA receptors. Science 260:95-97
33. Rossi DJ, Slater NT 1993 The developmental onset of NMDA receptor-channel activity during neuronal migration. Neuropharmacology 32:1239-1248
34. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P 1995 Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15:961-973
35. Ankarcrona M, Zhivotovsky B, Holmstrom T, Diana A, Eriksson JE, Orrenius S, Nicotera P 1996 Lamin and β-tubulin fragmentation precede chromatin degradation in glutamate-induced neuronal apoptosis. Neuroreport 7:2659-2664
36. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA 1995 Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92:7162-7166
37. Finiels F, Robert JJ, Samolyk ML, Privat A, Mallet J, Revah F 1995 Induction of neuronal apoptosis by excitotoxins associated with long-lasting increase of 12-O-tetradecanoylphorbol 13-acetate-responsive element-binding activity. J Neurochem 65:1027-1034
38. McDonald JW, Johnston MV 1993 Excitatory amino acid neurotoxicity in the developing brain. NIDA Res Monogr 133:185-205
39. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S 1991 Molecular cloning and characterization of the rat NMDA receptor [see comments]. Nature 354:31-37
40. Yamazaki M, Mori H, Araki K, Mon KJ, Mishina M 1992 Cloning, expression and modulation of a mouse NMDA receptor subunit. FEBS Lett 300:39-45
41. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M, Mishina M 1992 Molecular diversity of the NMDA receptor channel [see comments]. Nature 358:36-41
42. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Bumashev N, Sakmann B, Seeburg PH 1992 Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256:1217-1221
43. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M, Nakanishi S 1993 Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268:2836-2843
44. Kohr G, Eckardt S, Luddens H, Monyer H, Seeburg PH 1994 NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron 12:1031-1040
45. Watanabe M, Inoue Y, Sakimura K, Mishina M 1992 Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 3:1138-1140
46. Sheng M, Cummings J, Roldan LA, Jan YN, Jan LY 1994 Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368:144-147
47. Forrest D, Yuzaki M, Soares HD, Ng L, Luk DC, Sheng M, Stewart CL, Morgan JI, Connor JA, Curran T 1994 Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 13:325-338
48. Li Y, Erzurumlu RS, Chen C, Jhaveri S, Tonegawa S 1994 Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell 76:427-437
49. Kutsuwada T, Sakimura K, Manabe T, Takayama C, Katakura N, Kushiya E, Natsume R, Watanabe M, Inoue Y, Yagi T, Aizawa S, Arakawa M, Takahashi T, Nakamura Y, Mori H, Mishina M 1996 Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron 16:333-344
50. Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, Yagi T, Aizawa S, Inoue Y, Sugiyama H, Mishina M. 1995 Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature 373:151-155
51. Yuzaki M, Forrest D, Curran T, Connor JA 1996 Selective activation of calcium permeability by aspartate in Purkinje cells. Science 273:1112-1114
52. Bronner Fraser M, Wolf JJ, Murray BA 1992 Effects of antibodies against N-cadherin and N-CAM on the cranial neural crest and neural tube. Dev Biol 153:291-301
53. Cremer H, Chazal G, Goridis C, Represa A 1997 NCAM is essential for axonal growth and fasciculation in the hippocampus. Mol Cell Neurosci 8:323-335
54. Kirby ML, Gale TF, Stewart DE 1983 Neural crest cells contribute to normal aorticopulmonary septation. Science 220:1059-1061
55. Kirby ML, Turnage KLd, Hays BM 1985 Characterization of conotruncal malformations following ablation of "cardiac" neural crest. Anat Rec 213:87-93
56. Kirby ML, Waldo KL 1990 Role of neural crest in congenital heart disease. Circulation 82:332-340
57. Holland PW, Graham A 1995 Evolution of regional identity in the vertebrate nervous system. Perspect Dev Neurobiol 3:17-27
58. Witt G, Rosenquist TH, Gadson PF 1997 Homocysteine inhibition of PAX-3 expression. FASEB J 11:A427
59. Lipton SA 1993 Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci 16:527-532
60. Faden AI, Salzman S 1992 Pharmacological strategies in CNS trauma. Trends Pharmacol Sci 13:29-35
61. Perucca E 1993 The clinical pharmacology of the new antiepileptic drugs. Pharmacol Res 28:89-106
62. Thomas RJ 1995 Excitatory amino acids in health and disease. J Am Geriatr Soc 43:1279-1289
63. Elliott K, Kest B, Man A, Kao B, Inturrisi CE 1995 N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development. Neuropsychopharmacology 13:347-356
64. Purdon SE, Mohr E, Ilivitsky V, Jones BD 1994 Huntington's disease: pathogenesis, diagnosis and treatment. J Psychiatry Neurosci 19:359-367
65. Lipton SA 1992 Models of neuronal injury in AIDS: another role for the NMDA receptor? [see comments]. Trends Neurosci 15:75-79
66. Lipton SA 1994 HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists. Mol Neurobiol 8:181-196
67. Barry SR 1991 Clinical implications of basic neuroscience research. II. NMDA receptors and neurotrophic factors. Arch Phys Med Rehabil 72:1095-1101
68. Ossowska K 1994 The role of excitatory amino acids in experimental models of Parkinson's disease. J Neural Transm Parkinson's Dis Dementia Sect 8:39-71
69. Rogawski MA 1993 Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2:3-benzodiazepines. Trends Pharmacol Sci 14:325-331
70. Kazis A, Kimiskidis V, Niopas I 1996 Pharmacokinetics of dextromethorphan and dextrorphan in epileptic patients. Acta Neurol Scand 93:94-98
71. Nagai N, Kawakubo T, Kaneko F, Ishii M, Shinohara R, Saito Y, Shimamura H, Ohnishi A, Ogata H 1996 Pharmacokinetics and polymorphic oxidation of dextromethorphan in a Japanese population. Biopharm Drug Dispos 17:421-433